The overall objective of this project is to identify the molecular and cellular basis for the immunoregulatory effects of cyclosporine, a naturally occurring cyclic polypeptide that has had major impact on clinical organ transplantation. The hypothesis that normal human peripheral blood T-cells distinguished from one another on the basis of expression of cell-surface antigens, and with distinct functional potential, have intrinsic differential sensitivity to the inhibitory activity of CsA will be tested. The experimental approach to test the hypothesis includes: (1) Isolation of phenotypically distinct and functionally relevent subsets of normal human T-cells. The CD4+ cells, and subsets of CD4+ cells (CD4+CD45R+, CD4+CD45R-, D4+Leu8+(p80+), CD4+p8O-, CD4+CD45R-p80+ r CD4+CD45R-p80- cells), CD8+ cells and subsets of CD8+ cells (CD8+CD1lb+ or CD8+CD1lb- cells) will be isolated by panning and fluorescence activated cell sorting (FACS) of normal human T-cells. (2) Utilization of two novel models of T-cell activation. Transmembrane signaling of T-cell subsets with the synergistic combinations of: sn-1,2-dioctanoylglycerol (DAG, physiologic activator of protein kinase C [PKC]) and ionomycin (Calcium ionophore) or crosslinked anti-CD2 and anti-CD3 monoclonal antibodies. (3) Determination of effects of CsA on T-cell activation parameters initiated with the novel stimuli described in 2. A functionally linked cascade of activation events pertinent to signal transduction, cellular signaling and functional programming and cell growth will be examined for sensitivity to CsA. The parameters examined for inhibition by CsA will include: (1) calcium mobilization, (2) PKC activation, (3) induction of gene expression for Interleukin-2 (IL-2), lL-2 receptor (IL-2R, alpha and beta chains), IL-4, Interferon-gamma and the protooncogene, c-myc, (4) cell surface and functional expression of IL-2R, (5) production of IL-2, IL-4 and IFN-gamma (6) cell cycle progression and proliferation. CsA' 5 effects will also be examined in the presence of recombinant IL-I, lL-2, IL-4 and/or IL-6. A novel methodology for mRNA analysis, sequential reverse transcription and polymerase chain reaction as well as Southern and Northern hybridization will be utilized for the transcriptional phenotyping of functionally relevent and phenotypically distinct subpopulations of normal human T-cells.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Immunological Sciences Study Section (IMS)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
Schools of Medicine
New York
United States
Zip Code
Suthanthiran, Manikkam; Hojo, Minoru; Maluccio, Mary et al. (2009) Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Trans Am Clin Climatol Assoc 120:369-88
Boffa, Daniel J; Luan, Fulung; Thomas, Dolca et al. (2004) Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res 10:293-300
Luan, Fu L; Ding, Ruchuang; Sharma, Vijay K et al. (2003) Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int 63:917-26
Maluccio, Mary; Sharma, Vijay; Lagman, Mila et al. (2003) Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation 76:597-602
Yang, Hua; Thomas, Dolca; Boffa, Daniel J et al. (2002) Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation 74:291-8
Luan, Fu L; Hojo, Minoru; Maluccio, Mary et al. (2002) Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation 73:1565-72
Shin, G T; Khanna, A; Ding, R et al. (1998) In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine. Transplantation 65:313-8
Khanna, A; Kapur, S; Sharma, V et al. (1997) In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine. Transplantation 63:1037-9
Shin, G T; Khanna, A; Sharma, V K et al. (1997) In vivo hyperexpression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine. Transplant Proc 29:284
Andjelic, S; Khanna, A; Suthanthiran, M et al. (1997) Intracellular Ca2+ elevation and cyclosporin A synergistically induce TGF-beta 1-mediated apoptosis in lymphocytes. J Immunol 158:2527-34

Showing the most recent 10 out of 21 publications